APA (7th ed.) Citation

LH, P., N, B., F, F., L, F., S, U., V, B., . . . G, L. (2025). Prediction of Maternal and Fetal Exposure to Escitalopram, Sertraline, and Paroxetine by Combining Human Ex Vivo Placenta Perfusion Data and Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics, 64(12), 1843. https://doi.org/10.1007/s40262-025-01574-5

Chicago Style (17th ed.) Citation

LH, Préta, Bouazza N, Foissac F, Froelicher L, Urien S, Buth V, Benaboud S, Tréluyer JM, and Lui G. "Prediction of Maternal and Fetal Exposure to Escitalopram, Sertraline, and Paroxetine by Combining Human Ex Vivo Placenta Perfusion Data and Physiologically Based Pharmacokinetic Modeling." Clinical Pharmacokinetics 64, no. 12 (2025): 1843. https://doi.org/10.1007/s40262-025-01574-5.

MLA (9th ed.) Citation

LH, Préta, et al. "Prediction of Maternal and Fetal Exposure to Escitalopram, Sertraline, and Paroxetine by Combining Human Ex Vivo Placenta Perfusion Data and Physiologically Based Pharmacokinetic Modeling." Clinical Pharmacokinetics, vol. 64, no. 12, 2025, p. 1843, https://doi.org/10.1007/s40262-025-01574-5.